Medical Disorders With Pregnancy PDF

Document Details

Uploaded by Deleted User

Aswan University

Prof. Dr. Mohamed S. Fahmy

Tags

pregnancy disorders medical disorders obstetrics gynecology

Summary

This presentation discusses various medical disorders associated with pregnancy, covering hypertension, preeclampsia, eclampsia, diabetes, and anemia. It details classifications, risk factors, clinical presentations, and management strategies.

Full Transcript

1 Medical Disorders With Pregnancy BY PROF. DR. MOHAMED S. FAHMY PROFESSOR OF OBSTETRICS & GYNECOLOGY HEAD OF THE OBSTETRICS & GYNECOLOGY DEPARTMENT ASWAN UNIVERSITY 2 Hypertensive disorders with pregnancy Hyper...

1 Medical Disorders With Pregnancy BY PROF. DR. MOHAMED S. FAHMY PROFESSOR OF OBSTETRICS & GYNECOLOGY HEAD OF THE OBSTETRICS & GYNECOLOGY DEPARTMENT ASWAN UNIVERSITY 2 Hypertensive disorders with pregnancy Hypertensive disorders with 3 pregnancy  Classification:  Hypertension: BP ≥140/90 mm Hg measured two times with at least 6-hour interval  Proteinuria: Urinary excretion of ≥0.3 g protein/24 hours specimen or 0.1 g/L  Gestational hypertension: BP ≥140/90 mm Hg for the fi rst time in pregnancy after 20 weeks, without proteinuria  Preeclampsia: Gestational hypertension with proteinuria  Eclampsia: Women with preeclampsia complicated with grand mal seizures and/or coma  HELLP syndrome: Hemolysis (H) Elevated liver enzymes (EL) Low platelet count (LP)  Chronic hypertension: Known hypertension before pregnancy or hypertension diagnosed fi rst time before 20 weeks of pregnancy  Superimposed preeclampsia or eclampsia: Occurrence of new onset of proteinuria in women with chronic hypertension Preeclampsia 4  DEFINITION:  Preeclampsia is a multisystem disorder of unknown etiology characterized by development of hypertension to the extent of 140/90 mm Hg or more with proteinuria after the 20th week in a previously normotensive and nonproteinuric woman.  The preeclamptic features may appear even before the 20th week as in cases of hydatidiform mole and acute polyhydramnios.  Incidence : 5-8% Preeclampsia 5 Risk factors:  o Primigravida: Young or elderly (first time exposure to chorionic villi)  o Family history: Hypertension, preeclampsia  o Placental abnormalities:   Hyperplacentosis: Excessive exposure to chorionic villi—(molar pregnancy twins, diabetes)   Placental ischemia.  o Obesity: BMI >35 kg/m2, Insulin resistance.  o Pre-existing vascular disease.  o Thrombophilias: [antiphospholipid syndrome, protein C, S deficiency, Factor V Leiden] Preeclampsia 6  Clinical types:  Mild:  Rise of blood pressure of more than 140/90 mm Hg but less than 160 mm Hg systolic or 110 mm Hg diastolic without significant proteinuria.  Severe:   A persistent systolic blood pressure above or equal to 160 mm Hg or diastolic pressure above 110 mm Hg.   Protein excretion of more than 5 g/24 h   Oliguria (10% → ↑ CFMF)   Control of Complications "as LASER for retinopathy" {advise against pregnancy if marked renal or retinal affection, ischemic heart, or HbA 1C >10%)   Shift to Insulin (Better control, less complications, Teratogenic ) Diabetes with pregnancy 33  o Ante-natal management:   Diet control:  Caloric intake 1800 - 2400 Kcal/d (30 Kcal/kg/d ± 300 Kcal in 3rd trimester) in the form of 20% proteins, 50% complex CHO, and 30% Polysaturated fat   Insulin therapy:   Hospitalization:  Early to adjust the dose, late (36 w) for planned delivery & any time of complication   Antenatal frequency:  Every 2wks till 32°d wk, then /wk till 36th wk then hospitalize.   Investigations to detect maternal complications:   Ante-natal fetal surveillance:  Assessment of development, malformations & growth  oU/S (18-20 w for CFMF), Echo (20 - 22 w for congenital heart diseases)  Assessment of fetal wellbeing: fetal kicks, Doppler, CTG & BPP (best) Diabetes with pregnancy 34  o Intra-partum management   Control during labor:  IV drip of glucose if hyperglycemia occurred give insulin OR 5% glucose+ 5 units crystalline Insulin every 5 hrs   Timing of delivery:  At 38 - 40 wks after assessment of fetal maturity  In repeated unexpected IUFD → termination before date of IUFD by 1-2 w   Method:  If no macrosomia or other indications of CS → vaginal delivery   Care of newborn: (in NNICU +EXPERT NEONATOLOGIST) 35 Anemia with pregnancy Anemia with pregnancy 36  Iron deficiency anemia with pregnancy  Physiology :  o This is the most common type of anemia, is the commonest pregnancy disorder  o "WHO recommended 30 - 60 mg/d for pregnancy with adequate Fe stores & 120 - 240 mg/d for pregnancy with inadequate Fe store"  o Daily absorption is 10% of supplied iron, 20% in pregnancy   Non-pregnant → l-2mg.   Early pregnancy → 2-5m.   Late pregnancy → 5-6mg. Iron deficiency anemia with 37 pregnancy   Causes of iron deficiency anemia  o Increased demand: e.g. in pregnancy.  o Decreased intake: e.g. diet deficiency, vomiting  o Increased loss: e.g. parasitic infestations, piles.   Clinical picture  o Symptoms & signs :  Angular stomatitis, Red glazed tongue, brittle nails, splenomegaly, headache, fatigue Iron deficiency anemia with 38 pregnancy To diagnose anemia: Hb% < 10.5 g% To diagnose iron deficiency: Investigation Blood picture → Hypo chromic microcytic anemia. s: Serum iron: ↓ (N =60-180 µg/dl) Serum ferritin decrease (reflects BM stores) < l0 ng /ml (1st abnormal test) Iron deficiency anemia with 39 pregnancy  Treatment  o Prophylactic:   Oral preparations (30 - 60mg/day) &eradicate any predisposing factors.   Forms: Fe++ fumarate, Fe++ gluconate, Fe++ sulfate  o Active TTT   Oral iron 120-240 mg/d (0.3-1 gm/wk)+ Folic acid [masked foliate deficiency].   Parental iron: If No response to oral therapy or intolerance (Nausea, vomiting, diarrhea). SC →allergy, IM →painful & sterile abscess, IV →thrombophlebitis   If failed or severe anemia →Transfusion of packed RBCs 40 THANK YOU

Use Quizgecko on...
Browser
Browser